FDA inspection

Changzhou Qianhong Biopharma Co., Ltd.: FDA inspection ending Apr 30, 2010

FDA inspection 661070 · No Action Indicated (NAI) · Changzhou

Key facts

Inspection ID 661070
Firm Changzhou Qianhong Biopharma Co., Ltd.
FEI number 3005275502
Address 128 Xueye Road, Xuejiazhen Xinbei
City Changzhou
Country China
Fiscal year 2010
Inspection end date Apr 30, 2010
Classification No Action Indicated (NAI)
Project area Drug Quality Assurance
Product type Drugs

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • No Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections